To further investigate the clinical implications of GLUD1 downregulation in ccRCC, the correlation between the GLUD1 mRNA level and survival rates of patients was analyzed based on the TCGA data. The gene discussed is GLUD1; the disease is nonpapillary renal cell carcinoma.